"Ibrutinib Treatment in Early Stage CLL Prolongs Time to Active Disease."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ibrutinib treatment extended time to active disease in early stage chronic lymphocytic leukemia. Click to show full abstract

Ibrutinib treatment extended time to active disease in early stage chronic lymphocytic leukemia.

Keywords: ibrutinib treatment; active disease; early stage; time active

Journal Title: Cancer discovery
Year Published: 2021

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended